Clinical Trial Update: A Study of a Topical Patch (AB001) in Patients With Chronic Low Back Pain [Phase 2]

View source ↗

Summary

Phase 2 trial of AB001 topical patch for chronic low back pain has completed. The study was sponsored by Frontier Biotechnologies Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• AB001

Snippet

Sponsor: Frontier Biotechnologies Inc. | Conditions: Chronic Low Back Pain | Phase 2 | Status: COMPLETED